No Data
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $163
Wells Fargo analyst Larry Biegelsen maintains $Johnson & Johnson(JNJ.US)$ with a hold rating, and maintains the target price at $163.According to TipRanks data, the analyst has a success rate of 57.9%
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' to Meet 2024 Guidance, Goldman Says
U.S. pharma giant Johnson & Johnson (NYSE:JNJ) will report its second-quarter 2024 earnings on Wednesday, July 17.As per data from Benzinga Pro, analysts estimate sales of $22.29 billion and
Citi Research's AI Hedge Stocks - Part II
Johnson & Johnson (JNJ): One of the Best Blue Chip Dividend Stocks Right Now According to Hedge Funds?
Johnson & Johnson (NYSE:JNJ) is an American pharmaceutical industry company that also specializes in healthcare consumer products.
Express News | On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K
Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing
Emergent Biosolutions (EBS) said in a regulatory filing Monday that its subsidiary, Emergent Manufacturing Operations Baltimore, and Johnson & Johnson's Janssen Pharmaceuticals unit have agreed to settle all disputes related to a manufacturing services agreement for Johnson & Johnson's COVID-19 vaccine.